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In Brief
Zhu et al. show that, although type I IFN signaling is required for activating AIM2 inflammasome in response to Francisella novicida in macrophages, these components have strikingly opposing effects in vivo. Deleterious type I IFN signaling dominates protective AIM2 inflammasome responses by inducing apoptotic cell death.
INTRODUCTION
Innate immune sensors mediate the recognition of pathogenassociated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) and are central regulators of host defense against microbial infections. Upon activation, immune sensors induce the production of inflammatory cytokines and interferons. Certain innate immune cytoplasmic sensors have a unique ability to form a caspase-1-activating multi-protein complex termed the inflammasome. These sensors include members of the nucleotide-binding domain, leucine-rich repeat containing protein (NLR) family, absent in melanoma 2 (AIM2), and pyrin (Man et al., 2017) . Of these, AIM2 binds directly to double-stranded DNA (dsDNA) and assembles the inflammasome to mediate the release of interleukin (IL)-1b and IL-18 and the induction of pyroptosis. AIM2 orchestrates protective inflammasome-dependent responses against microbial infection in vivo, including infection by the Gram-negative bacterial pathogen Francisella novicida (Man et al., 2017) .
Components of the type I interferon (IFN) signaling pathway are essential for the activation of AIM2 inflammasome during infection by F. novicida and Listeria monocytogenes (Cole et al., 2008; Fernandes-Alnemri et al., 2010; Henry et al., 2007; Jones et al., 2010; Man et al., 2015; Meunier et al., 2015; Rathinam et al., 2010) . During F. novicida infection, the DNA sensor cGAS and its adaptor STING mediate the production of type I IFNs, which in turn drive expression of effector proteins of cellautonomous immunity, leading to bacteriolysis and release of bacterial DNA for recognition by AIM2 (Man et al., 2017) .
Type I IFN signaling during bacterial infection in vivo can be beneficial or detrimental depending on the pathogen (Malireddi and Kanneganti, 2013) . Whereas type I IFN signaling is protective in mice infected with Streptococcus pneumoniae or Streptococcus pyogenes, it is detrimental in the case of F. novicida or L. monocytogenes (McNab et al., 2015) . The requirement for type I IFN signaling to activate the AIM2 inflammasome in macrophages is counterintuitive to the observation that type I IFN signaling is detrimental during in vivo infection with F. novicida, whereas the AIM2 inflammasome is protective. How the interplay between the opposing effects of these signaling pathways determines the outcome during F. novicida infection has remained unclear. Here, we showed that the detrimental effects of type I IFN signaling override protective AIM2 inflammasome responses.
RESULTS AND DISCUSSION
IFNAR Signaling Enhances Susceptibility to Infection by F. novicida A study has demonstrated non-redundant functions for type I IFN receptor subunits IFNAR1 and IFNAR2 independently of each other (de Weerd et al., 2013) . To directly compare the effects of IFNAR1 and IFNAR2 during F. novicida infection, we infected wild-type (WT) mice and mice lacking IFNAR1 (Ifnar1
) with F. novicida and monitored their survival. Whereas 60% of the infected WT mice died within 14 days, only 13% of the Ifnar1 À/À mice and 11% of the Ifnar2 À/À mice succumbed to infection ( Figure 1A ), suggesting that signaling by both IFNAR1 and IFNAR2 contributes to increased susceptibility to infection by F. novicida. The resistance to
F. novicida infection in Ifnar1
À/À mice is consistent with the observations of a previous study . Furthermore, only 8% of mice lacking the transcription factor IFN-regulatory factor (IRF) 9 (Irf9
), a component of IFN-stimulated gene factor 3 (ISGF3) transducing type I IFN signaling, succumbed to infection by F. novicida over 14 days, essentially phenocopying Ifnar1 À/À and Ifnar2 À/À mice ( Figure 1A ). IRFs are central components regulating type I IFN production in response to diverse pathogens. We found that Irf7 À/À and Irf3
Irf7
À/À mice were resistant to the infection ( Figure 1B ). However, mice lacking IRF5 (Irf5
), an IRF not critical for IFN production, were as susceptible as WT mice ( Figure 1B ). We also observed increased resistance in mice lacking STING (Sting gt/gt ) ( Figure 1B and Ifnar2 À/À mice had significantly lower bacterial burdens in the liver and spleen 3 days after infection compared with WT mice, while Aim2 À/À mice were more susceptible to infection and had a greater bacterial burden ( Figure 2B ). These results demonstrate that type I IFN signaling is dominant over AIM2 inflammasome during F. novicida infection in vivo. Because both IFNAR1 and IFNAR2 are required for mediating detrimental type I IFN signaling, it is likely that Ifnar1 À/À Aim2 À/À mice are also resistant to the infection, phenocopying Ifnar2
mice. An increased number of splenic CD4 + T cells in naive
Ifnar2
À/À Aim2 À/À mice is unlikely to contribute to the susceptibility ( Figure S1A ), because the bacterial burden in Ifnar2
Aim2
À/À mice was significantly lower than in WT mice 3 days after infection when T cell responses barely occurred. We next investigated whether type I IFN signaling was required for AIM2 inflammasome-induced IL-18 production in vivo during F. novicida infection. Reduced levels of IL-18 were observed in the sera of Aim2 À/À and Ifnar2
mice, confirming AIM2-dependent IL-18 production in the infected mice ( Figure 2C ). Ifnar2 À/À mice retained the ability to produce IL-18 after the infection, indicating inflammasome activation independent of type I IFNs in vivo ( Figure 2C 2E , and S1D). Consistent with previous reports (Man et al., 2015 (Man et al., , 2016 , transfection of poly(dA:dT) did not induce IL-1b release in WT BMDMs ( Figure 2E ), possibly due to an inability of poly(dA:dT) transfection in mediating IL-1b expression. Collectively, these results demonstrate that unlike in macrophages, AIM2 inflammasome activation in vivo is retained even in the absence of type I IFN signaling. Inflammatory Cytokine Production Is Intact in the Absence of Type I IFN Signaling Previous studies showed that type I IFNs suppress production of pro-inflammatory cytokines to prevent inflammationassociated damage and lethality during S. pneumonia infection (Castiglia et al., 2016) . To identify whether the levels of pro-inflammatory cytokines are differentially regulated by type I IFN signaling during infection by F. novicida, we analyzed a range of cytokines and chemokines 1 day after F. novicida infection, when WT, Ifnar2
, and Ifnar2
À/À mice had a similar bacterial burden ( Figure 3A) . Levels of the pro-inflammatory cytokines GM-CSF, tumor necrosis factor (TNF), IL-6, MIP1-a, IL-17, IL-12, and IFNg and the anti-inflammatory cytokine IL-10 in the liver were comparable among WT, Ifnar2 À/À , and
Ifnar2
À/À Aim2 À/À mice ( Figure 3B ). The levels of these proinflammatory cytokines were also similar in the sera of WT, Ifnar2
À/À , and Ifnar2
Aim2
À/À mice at this time point ( Figure 3C ). We also measured levels of the cytokines 2 days after infection, when bacterial burdens were similar among the animals (Figure S2A ). Whereas levels of TNF, IL-6, MIP1-a, IFNg, and IL-10 were similar in the liver ( Figure S2B ), levels of GM-CSF and IL-12 were decreased in both Ifnar2 À/À and Ifnar2
mice and the level of IL-17 was decreased in Ifnar2 À/À mice (Figure S2B) . We found similar levels of TNF, IL-6, MIP1-a, and IL-10 but increased levels IL-17 and IL-12 in the sera of Ifnar2 À/À and Ifnar2 À/À Aim2 À/À mice compared with WT animals ( Figure S2C ), which is consistent with a previous study , suggesting that circulating IL-17 and IL-12 may also contribute to host defense at this time point. The level of IFNg was reduced in Ifnar2 À/À Aim2 À/À mice, but not Ifnar2 À/À mice ( Figure S2C ).
This could be due to a lack of IL-18-induced IFNg production in Ifnar2 À/À Aim2 À/À mice ( Figure S2C ).
Type I IFN Signaling Controls Activation of Apoptotic Caspases and Cell Death
Type I IFN signaling has been shown to exert its detrimental effects to the host via induction of cell death during L. monocytogenes and Brucella abortus infection (McNab et al., 2015) . To determine whether type I IFN signaling promotes excessive cell death during F. novicida infection, we measured levels of apoptotic caspase-8, caspase-3, and caspase-7 in liver tissues of WT, Ifnar2
mice. In line with our hypothesis, the levels of cleaved caspase-8, caspase-3, and caspase-7 were lower in Ifnar2 Figures S3F and S3G ). Caspase-7 has been reported as a substrate of caspase-1 (Lamkanfi et al., 2008 induced cell death during viral and bacterial infections (McNab et al., 2015) . TRAIL binds to its receptor DR5 and triggers apoptosis by driving caspase-8-mediated caspase-3 and caspase-7 activation. We therefore hypothesize that type I IFN signaling may promote cell death through the TRAIL pathway. We measured expression levels of TRAIL and DR5 in the liver and found that expression of TRAIL was upregulated in the liver of WT mice 1 day after infection; however, the induction was abrogated in Ifnar2 À/À and Figures 4D, S4B , and S4C). DR5 was similarly induced between the animals ( Figures 4D, S4B , and S4C). The level of TRAIL was slightly reduced in Aim2 À/À mice after the infection, while the level of DR5 was similar ( Figures  S4D and S4E ). IFNg can induce TRAIL expression, in addition to type I IFNs (Park et al., 2004) . Infected Aim2 À/À mice may exhibit reduced IFNg production (Pierini et al., 2013) , which in turn leads to modest reduction in TRAIL. However, the reduction was not significant enough to reduce apoptosis in Aim2 Figure 4F ). Neutralization of TRAIL also appeared to decrease bacterial burdens in the liver and spleen 3 days post-infection ( Figure S4G ), demonstrating a detrimental role for TRAIL pathway during F. novicida infection in vivo. Moreover, WT mice that received TRAIL-neutralizing antibody had reduced levels of cleaved caspase-8, caspase-3, and caspase-7 compared with the control animals after the infection ( Figures S4H and S4I ), confirming that the TRAIL pathway leads to activation of apoptotic caspases during F. novicida infection.
In this study, we demonstrate that type I IFN induced apoptosis in the liver following F. novicida infection and that the pathogenic effects of type I IFN signaling dominate the protective AIM2 responses. Type I IFN signaling has been shown to enhance susceptibility to L. monocytogenes and B. abortus infection by promoting cell death in the spleen with an ability to induce Trail expression (Carrero et al., 2004 (Carrero et al., , 2006 de Almeida et al., 2011; O'Connell et al., 2004) . Moreover, Trail À/À mice have decreased bacterial burdens in the liver and spleen and reduced splenic cell death after L. monocytogenes infection (Zheng et al., 2004) . Increased apoptosis during F. novicida infection could lead to loss of hepatocytes, which have crucial roles in controlling infection (Zhou et al., 2016 ). An expansion of IL-17-producing gd T cells was attributed to the phenotype of Ifnar1 À/À mice in a previous study (Man et al., 2017) . However, in contrast to mice lacking type I IFN signaling, mice lacking IRF1, GBPs, or IRGB10 are susceptible to the infection due to impaired AIM2 inflammasome responses (Man et al., 2015 (Man et al., , 2016 . Activation of AIM2 inflammasome is IFNAR independent in vivo, so expression of IRF1, GBPs, and IRGB10 might be intact in mice lacking type I IFN signaling because of the redundant induction by other types of IFNs. Consistent with this, priming Ifnar1 À/À BMDMs with IFNg bypasses the requirement for type I IFN signaling in the activation of the AIM2 inflammasome induced by F. novicida infection (Meunier et al., 2015) . Overall, our work highlights the dominant role of type I IFN signaling, which exacerbates F. novicida infection in vivo, as opposed to the protective role of the AIM2 inflammasome.
EXPERIMENTAL PROCEDURES
Mice WT C57BL/6J mice were purchased from The Jackson Laboratory. Details on mutant mice are provided in Supplemental Experimental Procedures. Male and female mice that were 6-8 weeks old were used in this study. Animal studies were conducted according to protocols approved by the St. Jude Animal Care and Use Committee.
Bacterial Culture and Animal Infection F. novicida strain U112 was grown in BBL Trypticase soy broth (TSB) (BD) supplemented with 0.2% L-cysteine overnight at 37 C and then 1:10 subcultured for 4 hr before infection. Mice were infected subcutaneously with 1.5 3 10 5 or 2.25 3 10 5 of F. novicida in 200 mL PBS. For colony-forming unit (CFU) analysis, harvested liver and spleen were homogenized, plated onto TSB agar with 0.2% L-cysteine, and incubated overnight. For survival analysis following TRAIL neutralization, mice were injected intraperitoneally (i.p.) with 300 mg anti-TRAIL monoclonal antibody (mAb) (N2B2) or immunoglobulin G2a (IgG2a) (RTK2758) isotype control (BioLegend) on days 0, 1, and 2 post-infection. For the rTRAIL experiment, mice were injected i.p. with 10 mg rTRAIL (PeproTech) or PBS on the same day as infection. Details are provided in Supplemental Experimental Procedures.
Cytokine Analysis
Cytokine levels were determined by performing multiplex ELISA (Millipore) or IL-18 ELISA (MBL International) according to the manufacturers' instructions.
Statistical Analysis
GraphPad Prism 6.0 software was used for data analysis. Data are shown as mean ± SEM. Statistical significance was determined by performing t tests (two tailed), one-way ANOVA, or a log-rank test. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and four figures and can be found with this article online at https://doi.org/ 10.1016/j.celrep.2018.02.096.
